MYH11 and acute myeloid leukemia: The WHO classification is regularly updated, taking into consideration those molecular abnormalities resulting from the cytogenetic abnormalities; for example, AML M4Eo/inv(16)(p13q22) is now referred to as AML with inv(16)(p13q22);CBFB-MYH11 [14].